Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Machens, A. Spitschak, K. Lorenz, B. Pützer, H. Dralle (2011)
Germline RET sequence variation I852M and occult medullary thyroid cancer: harmless polymorphism or causative mutation?Clinical Endocrinology, 75
D. Siqueira, M. Romitti, A. Rocha, L. Ceolin, C. Meotti, Aline Estivalet, Márcia Puñales, A. Maia (2010)
The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.Endocrine-related cancer, 17 4
R. Pai, G. Nehru, P. Samuel, M. Paul, N. Thomas, Jennifer Premkumar, J. Hephzibah, N. Shanthly, R. Oommen, A. Nair, M. Seshadri, S. Rajaratnam (2011)
Mutational analysis of RET proto‐oncogene among patients with medullary thyroid carcinoma and ‘at risk’ carriers from IndiaClinical Endocrinology, 75
Patrícia Costa, R. Domingues, L. Sobrinho, Maria Bugalho (2005)
RET polymorphisms and sporadic medullary thyroid carcinoma in a portuguese populationEndocrine, 27
A. Ruiz, G. Antiñolo, R. Fernández, C. Eng, I. Marcos, S. Borrego (2001)
Germline sequence variant S836S in the RET proto‐oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish populationClinical Endocrinology, 55
A. Machens, K. Frank‐Raue, K. Lorenz, S. Rondot, F. Raue, H. Dralle (2012)
Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancerClinical Endocrinology, 76
S. Baumgartner-Parzer, R. Lang, L. Wagner, G. Heinze, Bruno Niederle, K. Kaserer, W. Waldhäusl, H. Vierhapper (2005)
Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma?The Journal of clinical endocrinology and metabolism, 90 11
We describe a case of recurrent primary hyperparathyroidism, manifested as 3 metachronous parathyroid adenomata, in a 50 year-old woman who also had Hashimoto hypothyroidism, gastric gastrointestinal stromal tumour (GIST), cysts in liver and kidneys, 5 intestinal polyps (one of these a villous adenoma), diverticulitis and telangiectasia of lips. She did not have medullary thyroid carcinoma (MTC). Genetic analysis of the CDC73 gene [for Hyperparathyroidism—jaw tumor (HPT-JT)], MEN1 for Multiple Endocrine Neoplasia Type1, CDKN1B for MEN4, SDHB and SDHD for Paraganglioma/Pheochromocytoma susceptibility, VHL for von Hippel-Lindau Syndrome, BMPR1A and SMAD4 for Juvenile Polyposis Syndrome (JPS) (sequencing and MLPA), karyotype and array CGH (44 K) were all normal. She was found to be homozygous for a synonomous germline variant in exon 14 (p. Ser836Ser) of the RET oncogene. This RET variant is of unclear clinical significance, and has been previously reported both in normal individuals and in individuals with MTC. It is unlikely that homozygosity for the RET variant has been casual in the multiple pathologies that our patient has developed.
Familial Cancer – Springer Journals
Published: Dec 15, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.